Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Csl Ltd ADR (CSLLY)

Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Csl Ltd ADR 655 Elizabeth Street Melbourne C3 3000 AUS

www.csl.com.au P: 61-3-9389-1911

Description:

CSL Ltd. is a biopharmaceutical company. It engages in researches, develops, manufactures and markets vaccines and plasma protein biotherapies to treat and prevent human medical conditions. The company's operating segments consists of CSL Behring and bioCSL. CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. bioCSL segment manufactures, sells and distributes vaccines, antivenoms and other pharmaceutical products primarily in Australia and New Zealand; as well as also manufactures and markets in vitro diagnostic products through Immunohaematology. It operates primarily in Germany, Switzerland and the United States. CSL Ltd. is headquartered in Parkville, Australia.

Key Statistics

Overview:

Market Capitalization, $K 100,613,168
Enterprise Value, $K 111,292,168
Shares Outstanding, K 966,505
Annual Sales, $ 13,310 M
Annual Net Income, $ 2,194 M
EBIT, $ 0 K
EBITDA, $ 3,900 M
60-Month Beta 0.76
% of Institutional Shareholders 0.03%
Float, K 966,505
% Float 100.00%
Short Volume Ratio 0.18

Growth:

1-Year Return 17.30%
3-Year Return -4.18%
5-Year Return 32.31%
5-Year Revenue Growth 68.16%
5-Year Earnings Growth 19.37%
5-Year Dividend Growth 202.94%

Per-Share Information:

Next Earnings Date 08/12/24
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 1.14
Annual Dividend Yield 1.10%
Most Recent Dividend 0.545 on 03/11/24
Next Ex-Dividends Date 03/11/24
Dividend Payable Date 10/14/14
Dividend Payout Ratio 0.00%

CSLLY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 29.64
Price/Earnings to Growth 2.04
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 16.48%
Debt/Equity 0.69
Price/Sales N/A
Price/Cash Flow 33.39
Price/Book 5.67
Book Value/Share 18.48
Interest Coverage 7.00

CSLLY Dividends

Date Value
03/11/24 $0.5450
09/08/23 $0.5950
03/08/23 $0.4850
09/02/22 $0.5400
03/04/22 $0.4700
09/01/21 $0.5400
03/03/21 $0.4700
09/09/20 $0.4850
03/10/20 $0.4120
09/09/19 $0.4430
03/14/19 $0.3800
09/10/18 $0.4050
03/13/18 $0.3480
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar